2016 - Webinar on FDA Audit Practices and the 10 Most Common Cited GMP Deficiencies

This webinar will look at changes in FDA’s approach to audits and the current method used to determine audit frequencies by using a system of risk assessments.
Within the industries of pharma, biotechnology and medical devices, the word ‘audit’ can cause anxiety when you are unaware of how your company’s practices and procedures compare to the rest of the industry. Part of successfully getting through a regulatory audit involves: knowing the applicable regulations, the audit approaches used by regulators, and the common areas of industry deficiencies.
In addressing all these key elements, this webinar will:
Provide attendees a better understanding of the current audit techniques used by the FDA and how they have changed over the years
Analysis of the top 10 most cited GMP drug manufacturing deficiencies over the last year
Review of the significant increase in the number of warning letters issued over the last four years
Review common areas of focus during audits
Provide a template that companies can use to evaluate their own state of compliance
Demonstrate examples to highlight various points discussed
Please Note: This webinar will NOT be available in the Recorded format. This is a LIVE ONLY training.
Areas Covered in the Session :
Changes in FDA audit approaches
Areas of focus during audits
Most commonly cited drug GMP deficiencies for 2012-2013
Increase in FDA enforcement actions
Interactive Q&A Session
Who Will Benefit:
Quality Assurance
Quality Control
Manufacturing
Validation
Production
Regulatory Compliance